Investors

Press Releases

All Releases

View Summary Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
May 8, 2012
PDF 111.6 KB Add to Briefcase
View Summary Regeneron Reports First Quarter 2012 Financial and Operating Results
Apr 26, 2012
PDF 28.3 KB Add to Briefcase
View Summary Regeneron to Report First Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on April 26, 2012
Apr 12, 2012
PDF 9.3 KB Add to Briefcase
View Summary Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP® (aflibercept)
Apr 5, 2012
PDF 18.2 KB Add to Briefcase
View Summary Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody
Mar 26, 2012
PDF 21.9 KB Add to Briefcase
View Summary Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody
Mar 21, 2012
PDF 13.5 KB Add to Briefcase
View Summary Regeneron Announces Change in Date for Presentation at Barclays Capital 2012 Global Healthcare Conference
Mar 9, 2012
PDF 9.3 KB Add to Briefcase
View Summary Regeneron and Bayer Announce Approval of EYLEA® (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
Mar 8, 2012
PDF 19.0 KB Add to Briefcase
View Summary Regeneron Announces March 2012 Investor Conference Presentations
Feb 28, 2012
PDF 9.4 KB Add to Briefcase
View Summary Regeneron Announces February 2012 Investor Conference Presentations
Feb 21, 2012
PDF 9.5 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
Feb 13, 2012
PDF 9.6 KB Add to Briefcase
View Summary Regeneron Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
Feb 13, 2012
PDF 38.3 KB Add to Briefcase
View Summary Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast
Feb 10, 2012
PDF 9.8 KB Add to Briefcase
View Summary Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
Jan 26, 2012
PDF 9.4 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the 30th Annual J. P. Morgan Healthcare Conference
Jan 3, 2012
PDF 9.3 KB Add to Briefcase
View Summary Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
Jan 3, 2012
PDF 11.0 KB Add to Briefcase
View Summary Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation
Jan 2, 2012
PDF 9.6 KB Add to Briefcase
View Summary Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity
Dec 5, 2011
PDF 20.4 KB Add to Briefcase
View Summary Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
Dec 1, 2011
PDF 9.3 KB Add to Briefcase
View Summary Regeneron and Bayer Initiate Phase 3 Clinical Program for the Treatment of Wet Age-Related Macular Degeneration in China
Nov 28, 2011
PDF 18.7 KB Add to Briefcase
Showing 101-120 of 229 Page: 1 2 3 4 5 6 7 8 9 10 ... 12  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)